BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29113636)

  • 1. Evaluation of Interventions in Clinical Pharmacist-Led Annual Medicare Wellness Visits Compared with Usual Care.
    Beliard RC; Merrey JW
    Consult Pharm; 2017 Nov; 32(11):687-699. PubMed ID: 29113636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
    Wilson CG; Park I; Sutherland SE; Ray L
    J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
    Thomas MH; Goode JV
    J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Economic Analysis of Pharmacist-Led Annual Wellness Visits.
    Mallouh MA; Briggs A; Hawkins S; Heffern C
    Sr Care Pharm; 2023 May; 38(5):185-192. PubMed ID: 37185146
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Pharmacist Involvement in Medicare Wellness Visits.
    Tran T; Miller H; Ivy D
    J Pharm Pract; 2020 Dec; 33(6):745-748. PubMed ID: 30808266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare Annual Wellness Visits: A Scoping Review of Current Practice Models and Opportunities for Pharmacists.
    Hohmann LA; Hastings TJ; Qian J; Curran GM; Westrick SC
    J Pharm Pract; 2020 Oct; 33(5):666-681. PubMed ID: 31232218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early in-hospital medication review by clinical pharmacists on health services utilization.
    Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B
    PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacist in improving quality measures that affect payments to physicians.
    Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
    Milfred-Laforest SK; Chow SL; Didomenico RJ; Dracup K; Ensor CR; Gattis-Stough W; Heywood JT; Lindenfeld J; Page RL; Patterson JH; Vardeny O; Massie BM
    J Card Fail; 2013 May; 19(5):354-69. PubMed ID: 23663818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of quality measure attainment with pharmacist-delivered Medicare annual wellness visits.
    Osae SP; Young HN; Fricks WP; Zillich AJ
    J Am Pharm Assoc (2003); 2022; 62(2):559-563. PubMed ID: 34799260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-Led Annual Wellness Visits: A Review.
    Osae SP; Rotelli A
    J Pharm Pract; 2021 Apr; 34(2):295-305. PubMed ID: 31645170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
    Kuo GM; Touchette DR; Marinac JS
    Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provision of annual wellness visits with comprehensive medication management by a clinical pharmacist practitioner.
    Woodall T; Landis SE; Galvin SL; Plaut T; Roth McClurg MT
    Am J Health Syst Pharm; 2017 Feb; 74(4):218-223. PubMed ID: 28179248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Pharmacy Services in a Multidisciplinary Specialty Pain Clinic.
    Semerjian M; Durham MJ; Mirzaian E; Lou M; Richeimer SH
    Pain Pract; 2019 Mar; 19(3):303-309. PubMed ID: 30403432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Clinical Pharmacy Interventions to Reduce Outpatient Use of High-Risk Medications in the Elderly.
    Weddle SC; Rowe AS; Jeter JW; Renwick RC; Chamberlin SM; Franks AS
    J Manag Care Spec Pharm; 2017 May; 23(5):520-524. PubMed ID: 28448781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to clinical pharmacy services in a pharmacist-physician covisit model.
    Ulrich IP; Lugo B; Hughes P; Doucette L; Creith BB; Flanagan S; Gilmer B
    Res Social Adm Pharm; 2021 Jul; 17(7):1321-1326. PubMed ID: 33153913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a pharmacy-driven inpatient discharge counseling service: impact on 30-day readmission rates.
    Still KL; Davis AK; Chilipko AA; Jenkosol A; Norwood DK
    Consult Pharm; 2013 Dec; 28(12):775-85. PubMed ID: 24322961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.